NASDAQ:AKBA
Akebia Therapeutics Stock News
$1.40
+0 (+0%)
At Close: May 08, 2024
Akebia Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
01:15am, Tuesday, 12'th May 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the pricing of an underwritten public o
Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q1 2020 Results - Earnings Call Transcript
01:14am, Tuesday, 12'th May 2020
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Q1 2020 Earnings Conference Call May 11, 2020, 16:30 ET Company Participants Vineet Jindal - VP, Corporate Communicati
6 Stock Charts To Watch: AMRS, CYTK, DRNA, LX, MRNA, VAPO
12:00am, Tuesday, 12'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Amyris Inc, BioCryst Pharmaceuticals Inc, Cytokinetics Inc. Read Harry Boxer's latest article on Investing.com
Akebia Therapeutics Announces Proposed Public Offering of Common Stock
08:01pm, Monday, 11'th May 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the commencement of a proposed underwri
How Akebia Therapeutics (AKBA) Stock Stands Out in a Strong Industry
12:36pm, Monday, 11'th May 2020
Akebia Therapeutics (AKBA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Akebia Therapeutics Announces Proposed $100M Public Offering of Common Stock
12:00am, Monday, 11'th May 2020Tricida, Inc. (TCDA) CEO Gerrit Klaerner on Q1 2020 Results - Earnings Call Transcript
05:25am, Sunday, 10'th May 2020
Tricida, Inc. (NASDAQ:TCDA) Q1 2020 Earnings Conference Call May 07, 2020, 04:30 PM ET Company Participants Jackie Cossmon - Vice President-Investor Relations &
Edited Transcript of AKBA earnings conference call or presentation 5-May-20 12:30pm GMT
10:28pm, Friday, 08'th May 2020
Q1 2020 Akebia Therapeutics Inc Earnings Call
Akebia Therapeutics to Present at RBC Capital Markets Global Healthcare Virtual Conference
12:00pm, Friday, 08'th May 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its President and Chief Executive
US$17.13 - That's What Analysts Think Akebia Therapeutics, Inc. (NASDAQ:AKBA) Is Worth After These Results
06:15pm, Thursday, 07'th May 2020
As you might know, Akebia Therapeutics, Inc. (NASDAQ:AKBA) just kicked off its latest quarterly results with some very...
Akebia Shares Climb on Positive Anemia Drug Study Results
03:24pm, Thursday, 07'th May 2020
Company hits 52-week high of $12.25 Continue reading...
OPKO Health, Inc. (OPK) CEO Dr. Phillip Frost on Q1 2020 Results - Earnings Call Transcript
02:52am, Thursday, 07'th May 2020
Call end: 17:12 OPKO Health, Inc. (NASDAQ:OPK) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants Yvonne Briggs - LHA IR Phillip Frost
